Biotech C Lin

96 posts

Biotech C Lin

Biotech C Lin

@BiotechCLin

Beigetreten Nisan 2026
2 Folgt59 Follower
Golden Pan
Golden Pan@golden_pan1·
欢迎订阅查看更多完整解析,里面有更多 ticker、KOL 原文链接,还有接下来几天要看的热议事件。每天5分钟看清推上被热议的股票都是怎么被讨论的 完整日报里还有: - 中东局势怎么推高油价和 10 年期美债 - SpaceX IPO 会不会抽走美股科技股流动性 - 6/10 CPI 和 $ORCL 财报对 AI 链条的影响 themarketbrew.com/twitter-digest/
中文
1
0
1
446
Golden Pan
Golden Pan@golden_pan1·
6/8 过去 24 小时,X 上最热的几只美股: $NVDA $MRVL $MU $INTC $AMD 来看看他们是怎么被讨论的吧👇
中文
3
0
2
734
Biotech C Lin
Biotech C Lin@BiotechCLin·
@JackMan724444 Yup my 38% delta was pretty spot on but will lose money on my bullspread bet unless the management decide to sell the company. I guess they intend to raise instead of sell. Longs holding shares will need hold longer until they got the label for the reward. Tough luck.
English
0
0
1
105
Jack Man
Jack Man@JackMan724444·
@BiotechCLin Extraordinary Data. Never dreamed of a 40 delta. Such bad luck on some folks getting cancer. Which had nothing to do with OBE. Stock would be $200 right now if that didn’t happen with the efficacy of OBE $ABVX
English
1
0
1
458
Biotech C Lin
Biotech C Lin@BiotechCLin·
$ABVX I am probably the closest one on X for the efficacy prediction. Molecularly, miR-124 is a known tumors suppressor not an oncogene yet two cancer cases show up in 50mg. There is just no way to predict bad luck like this. Biotech investing is hard for sure.
Biotech C Lin@BiotechCLin

$ABVX 130 patients de-escalated to 25mg → 68% still in clinical remission at week 144. ITT/NRI. 80% completion rate. 7 years of clean safety. For the upcoming phase 3 maintenance data, delta forecast now improves from ~30pp to ~38pp based on my model.

English
1
0
2
940
Serenity
Serenity@aleabitoreddit·
At $NVDA GTC/Computex in Taipei: I think we’ll hear about the next AI bottleneck. That’s owned by a .6 P/B potato farming company in Japan, with a 180 year history. Their owner cooks those potatoes in night markets for 160 yen a piece. But that same potato farming equipment used to grow potatoes with optimal sunlight. Is now required for optical alignment requirements for CPO. And their unique cooking technique is mandatory to address thermal requirements for Rubin. Can anyone guess?
English
461
47
1.4K
480.8K
Paradis Labs
Paradis Labs@ParadisLabs·
Researching the power semis theme is fun: Legacy 54V has become a bottleneck. $NVDA's 800 VDC is the optimal architecture for next gen power distribution. For 800 VDC: Looking at smaller MC names like: 1. $AOSL @ $1.36B - cover full 800VDC conversion chain w/ announced 800VDC support. 2. $WOLF @ $2.87B - indirect exposure via transformer front end. 3. $POWI @ $4.68B - collaborating w/ Nvidia on the main stages of 800VDC racks. 4. $NVTS @ $6.30B - pure-play GaN + SiC. Only one of these names to be selected for Nvidia's 800VDC Kyber/Rubin Ultra rack. $VICR are another name, but feel like a lot of pricing-in has happened over the last ~1 year. I personally already have large-cap exposure via: 1. $IFX (Infineon) - current favourite: broadest grid-to-core play + named Nvidia 800VDC partner. 2. $STM (STMicroelectronics) - complete SiC supply chain. For disclosure, I'll likely rotate out soon to fund smaller MC buys since their SiC book is mainly auto/industrial + the data center slice is still small. Will look to take positions in smaller MC names for more supercharged returns. So feel free to recommend any other relevant names. And will ofc post up any research along the way.
Paradis Labs tweet media
Paradis Labs@ParadisLabs

Core Themes: CPU HBM/NAND Burn-in / test Glass core substrates ABF/InP substrates 800G/1.6T transceivers CW lasers/ELS SiPh foundry InP epi FAU SiC/GaN Fuel cells Transformers

English
46
65
557
99.4K
Biotech C Lin
Biotech C Lin@BiotechCLin·
感謝大叔美股筆記@Unclestocknotes 轉發英文版本,讓我有動力做了一份中文版本的SGL Carbon 研究報告。 希望中文圈的朋友會喜歡我的投資論點。 SGL Carbon (ETR: SGL):NVIDIA 800V 供應鏈中,最後一個未被定價的關鍵節點。 全文在以下連結: open.substack.com/pub/biotechcli…
中文
0
0
0
2.6K
Biotech C Lin
Biotech C Lin@BiotechCLin·
In several months AI will say SiC grade graphite from SGL carbon is the bottleneck not just SiC powder. Mark my words asking this very same question next year $SGL SGL carbon will show up. The more I read my analysis the more I feel I need to FOMO it.
Biotech C Lin tweet mediaBiotech C Lin tweet mediaBiotech C Lin tweet media
English
0
0
0
378
Stocky
Stocky@Stocky43550713·
@aktien_max Ich habe auch im Bereich von 400$ Call-Positionen 500$ Dez.27 aufgebaut. Was hältst du aktuell von SGL Carbon. Bin gestern darauf aufmerksam geworden und habe eine kleine Position gekauft bevor sie gestiegen ist. Hier mal ein Substack: biotechclin.substack.com/p/sgl-carbon-s…
Deutsch
1
0
2
266
Biotech C Lin
Biotech C Lin@BiotechCLin·
@JenPorcelli @avidresearch I have no plan to post more on BHVN until obesity week for T-alpha. Again I think your company has great science and I do respect the team still working to create therapy for patients when most of you could have retired already with the Nurtec buyout.
English
0
0
0
55
Jen Porcelli
Jen Porcelli@JenPorcelli·
@BiotechCLin @avidresearch You created a Twitter account solely to track Biohaven? That's dedication! Attending any upcoming sell-side conferences? Happy to meet!
English
3
0
0
113
avidresearch
avidresearch@avidresearch·
So do we like $BHVN after R&D day?
English
5
0
2
2.9K
Biotech C Lin
Biotech C Lin@BiotechCLin·
@JenPorcelli @avidresearch The only issue is getting diluted 20 times VS 5 times to get to 40B market cap is a huge difference. Retails will rather buy the catalyst rumor and sell the news when everyone knows infinite dilution is coming. I will not hold onto Biohaven but will trade on the science.
English
0
0
0
60
Biotech C Lin
Biotech C Lin@BiotechCLin·
NVIDIA just published their official 800V DC Architecture partner list. SiC+GaN makers confirmed: ✓ Infineon $IFNNY (SiC + GaN) ✓ Onsemi $ON (SiC) ✓ STMicro $STM (SiC + GaN) ✓ Rohm $6963.T (SiC + GaN) ✓ Navitas $NVTS (GaN) All need graphite consumables SGL Carbon $SGL
Biotech C Lin tweet media
English
0
0
2
551
Biotech C Lin
Biotech C Lin@BiotechCLin·
@STL_Biotech Biotech is all about liquidity. With AI semi stocks and upcoming space X ipo sucking up all the hot money, biotech companies with massive burn rate will be forced to dilute at depressed price before seeing the next catalyst making people less willing to hold. They wont listen.
English
0
0
2
168
STL Biotech
STL Biotech@STL_Biotech·
To be clear, I DO think some of their pipe is going to work out (not the nonsense in these slides) I just think the gains may accrue to a whole new class of shareholders who waltz in 2-4 years later after I've been diluted to hell and make 0 return. $BHVN
STL Biotech@STL_Biotech

Is this a serious company ?

English
4
0
18
7.3K
Biotech C Lin
Biotech C Lin@BiotechCLin·
@daichi888 Thank you if you think it makes sense feel free to repost it.
English
0
0
1
15
Biotech C Lin
Biotech C Lin@BiotechCLin·
$SGL How did it move from 4.6 to 5.5 in less than 24h? I don’t even have any following. SGL carbon SE is a physical bottleneck most upstream of SiC power semiconductor chain. I should have loaded up before publishing it :(
Biotech C Lin@BiotechCLin

Full breakdown — why SGL Carbon SE (ETR:SGL) is the last unpriced node in NVIDIA's 800V SiC power semiconductor supply chain. Physics. Duopoly. Five demand vectors. Zero analyst coverage. Read the full analysis on substack $SGL #SiC #PowerSemiconductor #NVIDIA800V $COHR $WOLF

English
2
0
1
677
maxeo55
maxeo55@maxddc·
@BiotechCLin I dont think so. The market is too deep. I dont think your report will move marcet cap of 600 mio :D And you already wrote its a 5x thesis so why is 5%-10% change that bad? Still crazy cheap. Relax.
English
1
0
2
35
Biotech C Lin
Biotech C Lin@BiotechCLin·
@maxddc I kinda regret publishing this article now seeing it went up from 4.6 to 5.5 in less than 24 hour. I am perplexed that it didn’t get much read at all but it’s moving the needle.
English
1
0
1
31
Biotech C Lin
Biotech C Lin@BiotechCLin·
@maxddc I am hoping to buy the dip and accumulate over the year since the AI revenue is not coming in until end of 2027.
English
1
0
1
47